Metastatic Colon Cancer Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01198548High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal CancerTreatment